Learn · Articles
IFW 2026 talk recap
I gave my talk at IFW 2026 in Torino on Friday — "Critical Business Metrics of BSF Bio-waste Operation." Slides attached.
01 · The core idea
Biowaste recycling first
The core idea: treat black soldier fly as biowaste recycling first, and the whole value proposition changes. It's the untapped lever most business plans miss. The job is to recycle a tonne of organic waste at the lowest cost — and the larvae and frass aren't just a protein product, they're the discount that pushes that cost down, ideally below what the producer already pays to dispose of it. Their ceiling is roughly soy-meal parity, not a premium-protein multiple — and that's enough.
02 · The filter
Disprove the case first
So the question is never "is BSF profitable?" but "how many things line up at this site, and is anything a showstopper?" I start with a triangle — legislation, the biowaste (cost + quality), the BSF products (use-case + price) — and try to disprove the case first; you can't spec the larvae, you get what the substrate gives. Then a hard advantages checklist: cheap or free feedstock already on site, low-cost or grant-funded infrastructure, low-cost energy, a nearby buyer, permissive law, low labour. Only when advantages clearly outweigh disadvantages do detailed numbers make sense. Maybe one or two sites in ten get past that filter.
03 · Three cases
Three real cases
We ran the framework across three real cases — EU (planning), South Asia and Southern Africa (operating). All three work, none for the same reason:
- EU: law blocks larvae from feed, so it's a capital-handled waste utility — break-even gate fee ~$16/t, against the $55–165/t cities pay to incinerate.
- South Asia: free on-site waste, open feed channel, low CAPEX — +18% margin at a $0 gate fee, +37% selling larvae live.
- Southern Africa: EU-level output prices on a low-cost base — +4% rising to +30% live, building the whole chain yourself.
04 · Findings
CAPEX and the OPEX stack
Two findings stood out. CAPEX runs ~3× higher in the EU (~$87k vs ~$29–31k per tonne/day) — that's the civil envelope, not the biology. And the OPEX stack flips: labour is ~67% of cost in the EU versus ~14% in the developing cases. Same headline OPEX, opposite structure — the total tells you little, the stack tells you everything.
05 · The bottleneck
The business model, not the biology
The real bottleneck isn't biology — the process is mature. Projects fail on the business model: the interfaces to paying customers at both ends, the waste producer and the output buyer. Drying is the big cost lever; premium protein is out; the frontier — oil, chitin, functional protein, NPK — is real but short on references, so start with the low-hanging fruit and learn upward.
06 · The unlock
Working together
The unlock is working together: shared benchmarks, standard ways to contract waste and offtake, the missing interfaces built once instead of fifty times. Manna doesn't operate plants — we license the methodology and tools through joint ventures — so the value was never in hoarding numbers. Methodology shared openly; if you're weighing a case, my inbox is open.
Keep exploring
Related topics and pages
- IFW 2026 Torino — Pre-event teaser (Ykä personal) — the personal pre-event note for the same IFW 2026 talk
- BSF is a waste business — the waste-business framing this talk's argument builds on
- Where BSF Wins (a case with numbers) — a warm-climate case with the per-ton numbers behind the argument
Read next
- IFW 2026 Torino — Pre-event teaser (Ykä personal) — the personal pre-event note for the same IFW 2026 talk
- BSF is a waste business — the waste-business framing this talk's argument builds on
- Where BSF Wins (a case with numbers) — a warm-climate case with the per-ton numbers that decide it
- Use Case #4: Software-only, operator builds locally — a delivery case where the operator builds locally and takes only Manna MIND and the designs
Next step
Weigh a case with the full argument
Manna can take the same framework through the legislation, waste, products, advantages and costs of a specific BSF case.